The ERa signaling pathway is one of the most important and most studied pathways in human breast cancer, yet numerous questions still exist such as how hormonally responsive cancers progress to a more aggressive and hormonally independent phenotype. We have noted that human breast cancers exhibit a strong direct correlation between ERa and E-cadherin expression by immunohistochemistry, suggesting that ERa signaling might regulate E-cadherin and implying that this regulation might influence epithelial-mesenchymal transition (EMT) and tumor progression. To investigate this hypothesis and the mechanisms behind it, we studied the effects of ERa signaling in ERa-transfected ERa-negative breast carcinoma cell lines, the MDA-MB-468 and the MDA-MB-231 and the effects of ERa knockdown in naturally expressing ERa-positive lines, MCF-7 and T47D. When ERa was overexpressed in the ERa-negative lines, 17b-estradiol (E2) decreased slug and increased E-cadherin. Clones maximally exhibiting these changes grew more in clumps and became less invasive in Matrigel. When ERa was knocked down in the ERapositive lines, slug increased, E-cadherin decreased, cells became spindly and exhibited increased Matrigel invasion. ERa signaling decreased slug expression by two different mechanisms: directly, by repression of slug transcription by the formation of a corepressor complex of ligand-activated ERa, HDAC inhibitor (HDAC1), and nuclear receptor corepressor (N-CoR) that bound the slug promoter in three half-site estrogen response elements (EREs); indirectly by phosphorylation and inactivation of GSK-3b through phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt). The GSK-3b inactivation, in turn, repressed slug expression and increased E-cadherin. In human breast cancer cases, there was a strong inverse correlation between slug and ERa and E-cadherin immunoreactivity. Our findings indicate that ERa signaling through slug regulates E-cadherin and EMT.
Introduction
Two of the most important pathways in human breast cancer involve estradiol (E2)/ERa signaling and E-cadherin/snai1/slug signaling, the latter leading to epithelial-mesenchymal transition (EMT). The ERa signaling pathway is one of the most studied pathways, yet numerous questions still exist such as how hormonally responsive cancers progress to a more aggressive and hormonally independent phenotype.
The binding of E2 induces an activating conformational change within the ER, promoting dimerization and high-affinity binding to specific estrogen response elements (EREs) located within the regulatory regions of target genes. The action of ligand-activated ERa is not limited to genes with EREs. Ligand-activated ERa can interact in an indirect manner with the regulatory regions of target genes, lacking EREs. In any case, ligand activation of ERa sets off a complex series of gene activations in the human breast cancer cell.
The E-cadherin-snai1-slug-EMT pathway is another important pathway in human breast cancer progression thought to regulate tumor progression, invasion, and metastasis of certain types of human breast cancer (Hajra et al., 2002; Catalano et al., 2004) . The snail transcription family consisting of members, snai1 and snai2 (slug), is thought to repress E-cadherin expression, leading to EMT (Hajra et al., 2002) . Whereas the gene regulation of snai1 and its transcriptional regulation of E-cadherin fairly well studied, comparatively little is known about slug.
We had noted that human breast cancers exhibit a strong direct correlation between ERa and E-cadherin expression by immunohistochemistry. In an earlier study (Ye et al., 2008) , we had also shown that ERa signaling can directly suppress slug expression by transcriptional repression. Collectively, these earlier observations suggested to us that ERa signaling might globally regulate E-cadherin and EMT as well. We decided to test this hypothesis in this study.
Results
The stimulation of E2 results in a decrease in slug, an increase in snai1, and an increase in E-cadherin mRNA in ERa-transfected cells To investigate the effect of ERa on the expression of slug and snai1, we performed initially transient transfections of full-length ERa into ERa-negative MDA-MB-468 and MDA-MB-231 cells. The results depicted for the MDA-MB-468 cells showed that ERa was overexpressed in pcDNA6.2/V5-ERa-transfected cells but not in the empty (control) vector-transfected cells (Figure 1a) . Results in the MDA-MB-231 cells were similar. Although we observed a small increase in slug mRNA levels in cells transfected with pcDNA6.2/ V5-ERa alone in the absence of E2, we observed a more dramatic decrease in slug mRNA when these cells were treated with E2 ( Figure 1b) . The effects on snai1 were exactly the opposite (Figure 1b) .
For the stable transfections, we used blasticidin to initially select for 30 different clones of the MDA-MB-231 line and 35 different clones of MDA-MB-468. Of these, 48 clones overexpressed ERa by both real-time PCR and western blot. In the presence of E2, slug expression was dramatically decreased in all of these ERa overexpressing clones by real-time PCR (Figure 2a ). Snai1 expression, on the other hand, was surprisingly increased by real-time PCR (Figure 2b ). The clones with the most dramatic decreases in slug expression are depicted for the MDA-MB-468 line (Figure 2a ). Clone 9 of the MDA-MB-468 line showed the highest level of both ERa protein expression (Figure 2c ) and the lowest level of slug expression by real-time PCR (Figure 2a ). E-cadherin expression was increased as well by real-time PCR with clone 9 showing the highest levels ( Figure 2d ). The results of these stable transfection experiments confirmed the results of the transient transfection experiments. Collectively, the transfection experiments indicated that the stimulation of E2 resulted in the downregulation of slug mRNA, upregulation of snai1 mRNA, and upregulation of E-cadherin mRNA in the cells overexpressing ERa. When the clones (clone 9 and others) overexpressing ERa were treated with ERa siRNA knockdown, the effects on decreased slug, increased snai1, and increased E-cadherin were neutralized (data not shown).
Knockdown of ERa results in an increase in slug, a decrease in snai1, and a decrease in E-cadherin mRNA expression In addition to examining the effects of ERa overexpression, we decided to knockdown ERa in strong ERa-expressing lines, for example, MCF-7 and T47D to monitor the effects on endogenous slug expression, a situation perhaps more physiologically relevant than the situation of overexpression. Initially, transient knockdown experiments were carried out with ERa siRNA. Western blot showing ERa protein levels in MCF-7 cells were treated with or without ERa siRNA and with or without E2. ERa siRNA was effective at significant knockdown, which could not be reversed with E2 ( Figure 3a ). We observed a dramatic increase in slug mRNA by real-time PCR when ERa was knocked down. (Figure 3b ). In contrast, snai1 showed a significant decrease in expression (data not shown). Results with the T47D line were similar.
For permanent knockdowns, miRNA was transfected into parental MCF-7 and T47D cells and stable clones were selected with blasticidin. Totally, 72 clones were selected and studied. We observed that the expression of ERa was knocked down to different levels ( Figure 4a ). In these clones, slug was increased by real-time PCR (Figure 4b ), whereas snai1 was decreased (Figure 4c ). Clone 3 of MCF-7 showed the greatest ERa knockdown and the greatest slug increase. Clone 3 and many of the other clones expressing ERa miR still had appreciable levels of ERa mRNA. When we applied subsequent siRNA knockdown to these clones, we achieved a greater knockdown, a greater increase in slug, and a greater decrease in E-cadherin expression (data not shown).
Clones overexpressing ERa or exhibiting ERa knockdown exhibit alterations in slug and E-cadherin protein expression To examine whether the alterations in ERa resulted in alterations in protein levels of slug and E-cadherin, we examined clones with the greatest overexpression or knockdown of ERa for slug and E-cadherin protein levels by western blot. Clone 9 of the MDA-MB-468 line showed the lowest level of slug protein (Figure 5a ) and the highest level of E-cadherin expression (Figure 5b ). Clone 3 of the MCF-7 showed the highest level of slug protein (Figure 5a ) and the lowest level of E-cadherin expression (Figure 5b ). The MDA-MB-468 line was highly invasive, but its clone 9 exhibited reduced invasion (P ¼ 0.05) (Figure 6e ). MCF-7 cells were poorly invasive, but its clone 3 showed moderately high invasion (P ¼ 0.05) (Figure 6e ). The change in morphology and invasive properties in the situation of ERa overexpression or ERa knockdown also suggested a reversal or induction of EMT, respectively.
Ligand-activated ERa complex comprised of nuclear receptor corepressor binds to the regulatory regions of the slug promoter On the basis of the aforementioned findings of an inverse relationship of ERa signaling and slug, we hypothesized that ligand-activated ERa may directly bind to the promoter regulatory regions of slug and recruit known ERa coregulators to form transcriptional complexes that regulate transcription. As earlier studies had examined the snai1 promoter and found no evidence of direct ERa complex binding (Fujita et al., 2003) , we decided to study only the slug promoter. Earlier, we had demonstrated such a repressor complex can form in the MCF-7 line with E2 signaling (Ye et al., 2008) . A search for specific EREs located within the slug promoter using MatInspector Software (Genomatix Software, Ann Arbor, MI, USA) had not revealed any classical ERE sites. However, the search revealed three half-site EREs found at position À467, þ 182, and þ 241, respectively. To investigate whether ERa also forms a transcriptional complex at these sites within the slug promoter of the T47D line, we performed chromatin immunoprecipitation (ChIP) assays. In these studies, we used the T47D line as the positive control and the MDA-MB-231 line as the negative control. On the basis of the location of the putative half-site EREs, we chose a region of the slug promoter flanked by these sites and a region located far upstream as a negative control and also for normalization of ChIP signals between the two cell lines. In the T47D cells, E2 treatment led to the recruitment of ERa to the (À456 to À68) but not the (À2178 to À1973) region (Figure 7a ). In MDA-MB-231 cells, there was no association of ERa to either region (Figure 7b) . A number of different corepressors interacting with ligand-activated ERa had been identified in recent years, one of which is nuclear receptor corepressor (N-CoR). It had been demonstrated that N-CoR also had an important function in the regulation of ERa target genes (Keeton and Brown, 2005; Voss et al., 2005) by binding to ligand-activated ERa. It had also been demonstrated that IKKa and SRC-3 regulate ERa target genes, including cyclin D1 and c-myc (Park et al., 2005) by binding to ligandactivated ERa. For these reasons, we investigated whether these corepressors or coactivators associated with the slug promoter at the same (À456 to À68) site. In the T47D cells, E2 treatment led to the recruitment of N-CoR ( Figure 7c ) but not SRC-3 or IKKa (Figure 7d ) to the (À456 to À68) region of the slug promoter. These results suggested that in the ERa positive T47D line, N-CoR but not SRC-3 nor IKKa formed part of the transcriptional inhibitory complex and was involved in the ligand-activated ERa regulation of slug . Differences between the clones and control were statistically significant (P ¼ 0.01). MDA-MB-468 cells were maintained in phenol red-free DMEM supplemented with 5% DCC-FBS for 48 h. After 48 h, the cells were serum starved for 12 h and either untreated or treated with E2 for 4 h. Total RNA was extracted and analyzed for the expression by real-time PCR. Clone 9 again showed the highest levels of E-cadherin expression. Because of this, it was selected for subsequent studies.
ERa signaling regulates E-cadherin through slug Y Ye et al transcription. The location of the putative binding site of this transcriptional complex somewhere among the half-site EREs is depicted (Figure 7e ).
Histone deacytylase inhibition increases slug and decreases E-cadherin expression
In an earlier study (Ye et al., 2008) , we had shown that HDAC inhibitor (HDAC1) also forms part of the ERa transcriptional complex that binds to the slug promoter. To test whether histone deacytylase inhibition had an effect on the expression of slug and E-cadherin, we chose an ERa overexpressing clone of the MDA-MB-231 line (clone 6) that expressed high ERa, decreased slug, and increased E-cadherin. We used an HDACI (EMD Chemicals, Inc., Gibbstown, NJ, USA) on this clone (Figure 8a ). In addition, we examined the effects of HDAC inhibition on slug expression in the naturally occurring ERa positive T47D line ( Figure 8b ). Our results indicated that HDAC inhibition reversed the effects of E2, increased slug expression in both lines, and correspondingly decreased E-cadherin. The cells so treated with HDACI underwent a morphologic change to a more spindly phenotype (data not shown). Differences between knockdowns and control were statistically significant (P ¼ 0.01). Total RNA was extracted and analyzed for slug mRNA by real-time PCR. (b) Slug expression increased with ERa knockdown. These differences were statistically significant (P ¼ 0.01).
Figure 4
Results of permanent knockdown of ERa in the stable transfectants of the MCF-7 cells and its opposite effects on slug and snai1 expression. All these differences between the clones and controls were statistically significant (P ¼ 0.01). MCF-7 cells were transfected with plasmid pcDNA6.2-GW/EmGFP-miR that contained either ERa miRNA or negative control. Blasticidin-resistant clones were screened and analyzed for ERa (a), slug (b), and snai1 (c) by real-time PCR. Four such clones are depicted. As clone 3 showed the most ERa knockdown and the highest slug expression, it was selected for subsequent studies. Figure 5 The stable transfectants of MDA-MB-468 showing the most ERa overexpression and decrease in slug expression (clone 9) and the stable transfectants of MCF-7 showing the most significant ERa knockdown and slug increase (clone 3) were analyzed for (a) slug and (b) E-cadherin expression by western blot. Clone 9 showed decreased slug and increased E-cadherin relative to control; clone 3 showed increased slug and decreased E-cadherin relative to control. All these differences were statistically significant (P ¼ 0.05).
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Ligand-activated ERa inhibits GSK-3b activity, which also results in the downregulation of slug and upregulation of E-cadherin It had been shown earlier that E2 treatment led to the phosphorylation of GSK-3b that inactivated GSK-3b activity (Horlein et al., 1995; Cardona-Gomez et al., 2004; Mendez and Garcia-Segura, 2006) , and that activated GSK-3b inhibited the transcription of snai1 (Zhou et al., 2004; Bachelder et al., 2005) by binding to and phosphorylating snai1. So we wondered what the effects on slug would be. For these purposes, we used clone 9 of the MDA-MB-468 line and the MCF-7 line.
Phosphorylated GSK-3b was increased in clone 9 after E2 treatment (Figure 9a ), indicating that ligand-activated ERa mediated the phosphorylation of GSK-3b. Treatment of MCF-7 cells with E2 also resulted in an increase in phosphorylated GSK-3b (Figures 9b and c) .
We hypothesized that E2 ligand-activated ERa may be signaling through phosphoinositide 3-kinase (PI3K)/ protein kinase B (Akt), which resulted in the phosphorylation and inactivation of GSK-3b (Figures 9c-e) . We tested this hypothesis by examining the levels of phosphorylated Akt after E2 treatment of MCF-7 cells and blocking Akt activation with separate specific Morphological changes occurred in the transfected clones, suggesting EMT or its reversal. Control MDA-MB-468 grew as loosely adherent groups of cells (a). Its clone 9, however, which overexpressed ERa and E-cadherin grew in more compact groups suggestive of reverse EMT (b). MCF-7 cells grew as fairly tight aggregates (c). Its clone 3, which exhibited significant ERa knockdown and decreased E-cadherin acquired a more loosely adherent spindle cell morphology suggestive of EMT (d). In the Matrigel invasion assay (e), clone 9 was less invasive than its MDA-MB-468 parent or its mock-transfected control (P ¼ 0.05), whereas clone 3 was more invasive than its MCF-7 parent or its mock-transfected control (P ¼ 0.05). Results depict mean±s.d. of % invasion in five replicate experiments. The differences between the clones and their respective controls were statistically significant (P ¼ 0.05).
ERa signaling regulates E-cadherin through slug Y Ye et al inhibitors of PI3K, wortmannin, and LY 294002. As controls for the actions of wortmannin and LY 294002 as specific inhibitors of Akt, we used PD98059, a specific mitogen-activated protein kinase (MAPK) inhibitor and U0126, a specific MAP kinase kinase (MEK) inhibitor. E2 treatment resulted in an increase in phosphorylated Akt (Figures 9d and e) . The use of wortmannin or LY 294002 resulted in no changes in total GSK-3b ( Figures  9b and c) or total Akt (Figures 9d and e) but abolished E2-induced Akt and GSK-3b phosphorylations (Figures  9b-e) . As observed before, E2 treatment downregulated slug and upregulated snai1 but wortmannin reversed the effects of E2 on both of these genes (Figure 9f ). The MAPK and MEK inhibitors had no effect (Figure 9f ). LY 294002 had a similar effect in reversing the effects of E2 treatment on the downregulation of slug and the upregulation of snai1 (data not shown). These results indicated that ligand-activated ERa activated the PI3K/ Akt/GSK-3b pathway, which led to GSK-3b phosphorylation (inactivation). This, in turn, downregulated slug but upregulated snai1. Predictably, E-cadherin expression increased (data not shown). To investigate this relationship further, we used a general GSK-3b inhibitor, LiCl to treat the MCF-7 line.
E2 and LiCl separately and together decreased slug expression but increased snai1 expression (Figure 9g ). These effects were not abolished when wortmannin or LY 294002 was added to the mixture (data not shown). Our studies, while confirming the findings of other investigators (Zhou et al., 2004; Bachelder et al., 2005) that GSK-3b inhibition stimulated snai1 expression, observed that GSK-3b inhibition suppressed slug expression. Although LiCl is a general but not specific inhibitor of GSK-3b, having other effects in the cell, for example, activation of Akt which, in turn, may trigger other signaling events than just GSK-3b inactivation, our conclusions with respect to the LiCl experiments Figure 7 ChIP assays for the ligand-activated ERa transcriptional complex in association with the slug promoter. (a) ERa-positive T47D cells were grown in phenol red-free DMEM supplemented with 5% DCC-FBS for 48 h. After 12 h of serum starvation, the cells were treated with either ethanol vehicle (control) or E2 (100 nM) for 4 h. ChIP assays were performed by using an antibody directed against ERa. E2 treatment led to the recruitment of ERa to the (À456 to À68) but not the (À2178 to À1973) region of the slug promoter. (b) The ERa-negative MDA-MB-231 cells were similarly grown, treated, and studied. There was no association of ERa to either region of the slug promoter with E2 treatment. Additional ChIP assays on the T47D cells were performed using antibodies directed against N-CoR (c), IKKa and SRC-3 (d). E2 treatment led to the recruitment of N-CoR but not SRC-3 or IKKa to the (À456 to À68) region of the slug promoter. Input DNA was used to normalize the results in all sets of experiments. All of the aforementioned differences in respective PCR product intensities were statistically significant (P ¼ 0.01). (e) Schematic shows the location of the putative binding site of the transcriptional complex among the half-site EREs. Figure 8 Effect of histone deacytylase inhibition on slug expression. (a) MDA-MB-231, clone 6, which overexpressed transfected ERa and showed maximal slug inhibition with E2 was incubated in phenol red-free DMEM supplemented with 5% DCC-FBS for 48 h, followed by 12 h of serum starvation. Cells were then incubated for 4 h with or without E2 (100 nM) and with or without an HDAC inhibitor (4 mM) (HDACI). Total RNA was extracted and analyzed for slug mRNA by real-time PCR. Whereas E2 decreased slug expression, HDACI increased slug expression. These differences were all statistically significant (P ¼ 0.05). (b) T47D cells were similarly treated and analyzed and showed similar results on slug with E2 and HDACI treatment. These differences were all statistically significant (P ¼ 0.05). (c) The results of HDACI treatment on E-cadherin expression is depicted. HDACI decreased E-cadherin in both the T47D cells and clone 6 of MDA-MB-231 relative to their non-treated controls. These differences were all statistically significant (P ¼ 0.05).
were supported by the fact that wortmannin and LY 294002, specific inhibitors of PI3K and blockers of Akt activation, did not alter the results with LiCl.
Slug trumped snai1 in the regulation of E-cadherin and EMT As in the situations of both ERa overexpression and ERa knockdown, the effects on slug and snai1 were opposite. However, the effects on E-cadherin and EMT were always in the direction of slug, not snai1 (Figures 1,  2 , 4, 9, and 10; Table 1 ). When slug increased, E-cadherin decreased and EMT increased. When slug decreased, E cadherin increased and EMT reversed.
Slug but not snai1 inversely correlated with ERa and E-cadherin in human breast cancer
In analyzing a 500-member tissue microarray (TMA), the immunohistochemical expression of ERa directly correlated strongly with E-cadherin (Table 1) . Slug expression inversely correlated strongly with both ERa and E-cadherin ( Figure 10 ). Snai1 did not significantly correlate with any of the previously mentioned markers (Table 1) . Schematic then depicts ERa signaling through slug regulating E-cadherin and EMT (Figure 11 ). Figure 9 Ligand-activated ERa signaling through PI3K/Akt/GSK-3b. (a) The MDA-MB-468 clone 9 and a control clone were grown in phenol red-free DMEM supplemented with 5% DCC-FBS for 48 h, and after 12 h of serum starvation, cells were treated with E2 (100 nM) for 4 h. Total protein extracts were analyzed by western blot for total and phosphorylated GSK-3b. E2 induced increased GSK-3b phosphorylation in clone 9. The differences were statistically significant (P ¼ 0.05). (b-e) MCF-7 cells were grown in phenol red-free DMEM supplemented with 5% DCC-FBS for 48 h, and after 12 h of serum starvation, cells were treated with E2 (100 nM) for 4 h and with the addition of wortmannin (200 nM) or LY 294002 (20 mM). Total protein extracts were analyzed by western blot for total and phosphorylated GSK-3b (b, c) and total and phosphorylated Akt (d, e). E2 increased both phosphorylated GSK-3b (b, c) and phosphorylated Akt (d, e) but wortmannin (b, d) or LY 294002 (c, e) abolished this E2-induced phosphorylation. These differences were all statistically significant (P ¼ 0.05). (f) MCF-7 cells were similarly grown and treated with E2 or combined with wortmannin (200 nM), or PD98059 (20 mM) (an MAPK inhibitor) or U0126 (10 mM) (an MEK inhibitor) for 4 h. These inhibitors were added at the same time as E2. Total RNA was extracted and analyzed for slug (top panel) or snai1 (bottom panel) by real-time PCR. Wortmannin treatment reversed the effects of E2 on slug downregulation or snai1 upregulation. The differences with wortmannin treatment were all statistically significant (P ¼ 0.05) but the differences with PD98059 or U0126 were not (P ¼ 0.1). (f) Effects of a GSK-3b inhibitor, LiCl, on slug (top panel) and snai1 (bottom panel) expression in MCF-7 cells. MCF-7 cells were grown in six-well plates and incubated in phenol red-free DMEM supplemented with 5% DCC-FBS for 48 h, followed by 12 h of serum starvation. Cells were then treated with or without E2, and with or without LiCl for 4 h. Total RNA was extracted and analyzed for slug or snai1 by real-time PCR. Both E2 and LiCl inhibited slug but increased snai1 expression. All these differences were statistically significant (P ¼ 0.05). 
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Discussion
Two of the most common signaling pathways in breast cancer are the ERa-signaling pathway and the Ecadherin-snai1-slug-EMT pathway (Tora et al., 1989; Hyder et al., 1996; Kato et al., 2000; Mueller et al., 2000; Nilsson et al., 2001; Hall and McDonnell, 2005) . Despite the studies that have been conducted on these two pathways to date, numerous questions still exist in human breast cancer such as how initially hormonally responsive cancers progress to a more aggressive and hormonally independent phenotype and whether EMT has a function in this progression. Our laboratory had been studying E-cadherin expression in a series of ERa positive and ERa negative human breast cancer cell lines (Tomlinson et al., 2001; Alpaugh et al., 2002a, b) when we observed by expression profiling that many ERa negative lines, which were also E-cadherin negative, exhibited high slug expression (Barsky, 2003) . These observations suggested that ERa signaling might regulate E-cadherin and implied that this regulation might influence EMT and tumor progression. To investigate this hypothesis further and the mechanisms behind it, we studied the effects of ERa signaling in ERa-transfected ERa-negative breast carcinoma cell lines and the effects of ERa knockdown in naturally expressing ERa-positive lines in this study. When ERa was overexpressed in the ERa-negative lines, 17b-E2 decreased slug and increased E-cadherin. Clones maximally exhibiting these changes became less invasive in Matrigel. When ERa was knocked down in the ERapositive lines, slug increased, E-cadherin decreased, and clones changed morphologically to a spindle cell shape and exhibited increased Matrigel invasion.
ERa regulated slug by two mechanisms: the first mechanism involved the ligand-activated ERa suppression of slug transcription through direct association with the slug promoter, where ERa interacted with recruited corepressors, N-CoR and HDAC1. Although the prevailing belief was that agonist-liganded ERa is associated with gene activation and that the recruitment of gene repression components such as HDAC1 by ERa to target gene promoters occurs only when ERa is liganded with antagonists (Hall and McDonnell, 2005) , here and in an earlier study (Ye et al., 2008) , we showed that this belief is not universally true: that agonist-
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Slug Snai1 E-cadherin Figure 10 Representative fields of view (FOV) from the TMA cores shows examples of positive ERa, negative slug, positive snai1, and positive E-cadherin (upper row) and negative ERa, positive slug, negative snai1, and negative E-cadherin (lower row). ERa, slug, and snai1 exhibited nuclear immunoreactivity and E-cadherin membrane immunoreactivity. Correlations among these markers from these human cases were analyzed algorithmically. Results are depicted in Table 1 .
ERa signaling regulates E-cadherin through slug Y Ye et al activated ERa can associate with corepressors (N-CoR and HDAC1) to suppress gene (slug) expression. Although it had been noted that ERa can repress the expression of snai1 through the activation of MTA3 that selectively targeted snai1, direct effects on snai1 transcription were not found (Fujita et al., 2003) . In this study, we found direct effects of ERa on slug transcription. Our findings indicated that ligand-activated ERa forms together with HDAC1 and N-CoR a transcriptional inhibitory complex, which likely binds to the slug promoter in a region containing the half-site EREs. As we did not know which of these half ERE sites might be the location of the binding of the transcription inhibitory complex, we chose a promoter region flanked by these sites that would likely be precipitated in the ChIP analyses if any of these half ERE sites were involved. Our findings still do not indicate the precise location of the binding of the complex or whether more than one half ERE site is involved. The second mechanism was that ligand-activated ERa inhibited GSK-3b activity through activation of the PI3K/Akt/GSK-3b pathway, which led to GSK-3b phosphorylation (inactivation). Although earlier studies had shown that activated GSK-3b inhibited expression of snai1 (Zhou et al., 2004; Bachelder et al., 2005) , our study is the first to show that slug is also regulated by GSK-3b. It had been shown earlier that E2 treatment resulted in GSK-3b phosphorylation and inactivation (Medunjanin et al., 2005) mediated by the PI3K/Akt pathway (Keeton and Brown, 2005; Park et al., 2005; Voss et al., 2005) . It had not been shown, however, that GSK-3b inactivation inhibited slug expression, and we have shown this in this study by using a general GSK-3b inhibitor, LiCl, which decreased slug expression. Ligand-activated ERa also phosphorylated and inhibited GSK-3b activity through the PI3K/Akt pathway, which led to decreased slug expression. When Akt phosphorylation (activation) was inhibited with two different PI3 K inhibitors, wortmannin and LY 294002, E2-induced Akt and GSK-3b phosphorylations were abolished. As wortmannin and LY 294002 separately nearly restored slug levels to baseline and reversed the effects of E2, it is likely that the action of ligandactivated ERa through PI3K/Akt/GSK-3b on slug suppression is greater than its direct effect on slug transcription at the slug promoter. The mechanisms by which GSK-3b (and its activation) regulate slug expression are not known and beyond the scope of this study. The usual and most important function of GSK-3b is to complex with other proteins, for example, transcription factors and to control their function by phosphorylation (de Groot et al., 1993; Fiol et al., 1994; Hoeflich et al., 2000; Frame and Cohen, 2001; Turenne and Price, 2001; Watcharasit et al., 2003) . GSK-3b, in turn, can be inactivated by different mechanisms by different pathways. For example, the Wnt pathway can inactivate GSK-3b by disintegration of its protein complex and the PI3K/Akt pathway can inactivate GSK-3b by phosphorylation (Keeton and Brown, 2005; Park et al., 2005; Voss et al., 2005) . LiCl also inactivated GSK-3b, and we used this approach to show that this inactivation decreased slug expression. But LiCl is not a specific inhibitor of GSK-3b. Indeed LiCl is thought to inhibit GSK-3b by two different mechanisms: the inhibition of the catalytic activity of GSK-3b and the phosphorylation of GSK-3b through LiCl's activation of Akt. As the activation of Akt may trigger more signaling events than just GSK-3b inactivation, the use of LiCl alone to inhibit GSK-3b may not have been definitive enough proof to conclude that GSK-3b inactivation inhibits slug expression directly. Our conclusions with respect to the LiCl experiments were buttressed by the fact that wortmannin and LY 294002, specific inhibitors of PI3K and blockers of Akt activation, did not alter the results of LiCl. Still definitive proof of the above claim will require additional experiments with small molecule GSK-3b inhibitors that will need to be used in addition to LiCl.
Inhibition of E-cadherin expression is thought to mediate, in part, EMT (Berx and Van Roy, 2001 ) that contributes to enhanced invasiveness and metastasis (Wong and Gumbiner, 2003; Hayashida et al., 2005) , increased tumor cell division (Sasaki et al., 2000; Perrais et al., 2007) , and activation of receptor tyrosine kinases (Qian et al., 2004) . Inhibition of E-cadherin expression can be the result of mutation and loss of heterozygosity (Hiraguri et al., 1998) , promoter methylation (Lombaerts et al., 2006; Roll et al., 2008) , and cis/trans interactions with transcriptional factors such as dEF (Yang et al., 2007), twist, snai1, and slug (MorenoBueno et al., 2006) . E-cadherin can also be regulated by ubiquination and degradation mechanisms (Yang et al., 2006) or by, as yet, unknown mechanisms (Nam et al., 2006) .
The relationship of E-cadherin, snai1, slug, and twist has been studied in both human cancer cell lines (Poser et al., 2001) as well as human cancers (Uchikado et al., 2005; Hotz et al., 2007; Natsugoe et al., 2007) . In some of these studies, an inverse correlation between snai1 Figure 11 Schematic summary of ERa-signaling through slug regulating E-cadherin and EMT. Membrane depicted (double lines) is the plasma membrane. PI3K/Akt/GSK-3b actions are occurring in the cytoplasm. ERa, HDAC1, NCoR, and GSK-3b actions on slug are occurring in the nucleus.
ERa signaling regulates E-cadherin through slug Y Ye et al and E-cadherin was observed, and in some studies slug expression inversely correlated with prognosis. These studies did not address the correlations between ERa, slug, snai1, and E-cadherin in human breast cancer that we observed in this study.
There have been a paucity of studies in human breast cancer investigating the relationship between ERa signaling and E-cadherin expression and these studies have given somewhat conflicting results. A direct correlation between the expression of ERa and E-cadherin has been observed although the mechanism of this observation was not addressed (Lacroix and Leclercq, 2004) . ERa was observed indirectly to suppress snai1 and increase E-cadherin by upregulating MTA3 (Fujita et al., 2003) . ERa was also observed to upregulate E-cadherin in an ERa negative line transfected with ERa but to downregulate E-cadherin in an ERa positive line (Moggs et al., 2005) . The function of slug in these studies was not investigated. ERa was observed to directly downregulate E-cadherin in breast cancer lines (Oesterreich et al., 2003) , but the effects of ERa on slug and snai1 were not studied. Studies in breast cancer lines and human cases have observed that both snai1 and slug can repress E-cadherin expression (Hajra et al., 2002; Come et al., 2006) although the effects of E2/ERa signaling were not addressed and slug was not studied immunocytochemically.
This work has focused on ERa signaling through slug regulating E-cadherin and EMT but there may be a bidirectional crosstalk between some of the molecules within these pathways in addition to bidirectional crosstalk between the pathways themselves. For example, GSK-3b has been shown to interact with and phosphorylate ERa and thereby regulate its activity (Medunjanin et al., 2005) . Other studies have shown that silencing of GSK-3b results in ERa ubiquination and downregulation in MCF-7 cells (Grisouard et al., 2007) . These latter studies suggest crosstalk between these molecules. Other work has shown crosstalk between snai1 and ERa, observing in MCF-7 cells that snai1 can mediate EMT by repression of ERa expression (Dhasarathy et al., 2007) .
It is interesting that in nearly all of our experimental manipulations, the effects on slug and snai1 were opposite and slug trumped snai1 in the regulation of E-cadherin and EMT. ERa overexpression decreased slug and increased snai1; ERa knockdown increased slug and decreased snai1; GSK-3b inhibition or inactivation decreased slug and increased snai1. As mentioned earlier, these two members of the snail family of transcription factors are thought to suppress E-cadherin expression and, in part, mediate EMT and would be anticipated to exhibit coordinated expression. But their expression was opposite indicating that slug and snai1 most likely have separate actions. A recent genetic profiling study, in fact, indicated that a substantial percentage of different genes were expressed in snai1 vs slug transfectants indicating that snai1 and slug each induce different genetic programs (MorenoBueno et al., 2006) involving different pathways. As slug trumped snai1 in the regulation of E-cadherin and EMT in both the experimental studies as well as the human correlative studies, we conclude that slug is more important than snai1 in the regulation of E-cadherin by ERa signaling. Whereas snai1 may be the more important transcriptional factor in regulating E-cadherin endogenously or constitutively, slug may be more important in regulating E-cadherin exogenously or from external stimuli, for example, E2.
Materials and methods
Reagents and antibodies
See 'Supplementary Information' available at the Oncogene website at the end of the article and before the references.
Cell culture
We used a series of commercially available human breast carcinoma lines, including the ERa positive MCF-7 and T47D lines and the ERa negative MDA-MB-231 and MDA-MB-468 lines.
Plasmid construction, transfections, and analysis For details, please see 'Supplementary Information.'
RNA isolation and cDNA synthesis RNA was isolated from cultured cells using RNAeasy Mini Kit (Qiagen, Inc., Valencia, CA, USA).
PCR and real-time PCR
Briefly, an aliquot of DNA was used in each 25 ml PCR reaction under standard conditions. Preparation of protein lysates and western blot analysis Cells were lysed using ice-cold RIPA lysis buffer (50 mM Tris, 150 mM NaCl, 50 mM NaF, 1 mM Na 4 P 2 O 7 Á 10H 2 O, 0.1% DOC, 1.0% NP-40, 50 ml Na 3 VO 4 , and Halt Protease Inhibitor Cocktail) (Pierce Technology, Inc., Rockford, IL, USA).
ChIP analysis
The ChIP assay was performed using a ChIP kit (Millipore Corporation, Inc., Billerica, MA, USA) according to the manufacturer's instructions.
Analyses of cell morphology and invasion
Selected clones produced by the stable transfections of ERa into the MDA-MB-468 line and ERa knockdown in the MCF-7 line were studied morphologically by phase contrast microscopy and in the Matrigel invasion chamber and compared with their parental lines and their vector only transfections and control knockdowns.
Construction and analysis of human TMAs
TMAs were manually constructed from 500 cases of human breast cancer, scanned into virtual TMAs and measured algorithmically using nuclear and membrane immunocytochemical algorithms Sharangpani et al., 2007) . 
Statistical analysis
